Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
11/13/2008 | US20080279906 Intracellular delivery of endothelial growth factor |
11/13/2008 | US20080279882 Phyto-nutraceutical synergistic composition for hyperlipedemic condition |
11/13/2008 | US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells |
11/13/2008 | US20080279864 High Throughput Screen Utilizing Newly Discovered Intramolecular Neuronal Calcium Channel Interactions To Discover New Analgesics |
11/13/2008 | US20080279857 Therapeutic Agent |
11/13/2008 | US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation |
11/13/2008 | US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof |
11/13/2008 | US20080279835 Using human umbilical cord progenitor cells to propagate myocardial tissues to treat coronary disease; tissue engineering and repair; regenerative medicine |
11/13/2008 | DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use |
11/13/2008 | DE102007021862A1 Wässrige pharmazeutische Zubereitung Aqueous pharmaceutical preparation |
11/13/2008 | CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
11/13/2008 | CA2688317A1 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations |
11/13/2008 | CA2686736A1 Methods and compositions for treating pulmonary hypertension |
11/13/2008 | CA2686707A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals |
11/13/2008 | CA2686457A1 Novel polymorphic forms |
11/13/2008 | CA2686396A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
11/13/2008 | CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity |
11/13/2008 | CA2684722A1 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
11/13/2008 | CA2684703A1 Bicyclic compound and pharmaceutical use thereof |
11/13/2008 | CA2683760A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
11/12/2008 | EP1990343A2 Azaindoles |
11/12/2008 | EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators |
11/12/2008 | EP1990053A1 Pharmaceutical composition for enhancing adiponectin production |
11/12/2008 | EP1990052A1 Pharmaceutical package |
11/12/2008 | EP1990049A2 Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID) |
11/12/2008 | EP1988916A1 Methods and agents for reducing oxidative stress |
11/12/2008 | EP1988892A2 Modulators of muscarinic receptors |
11/12/2008 | EP1988885A2 Combination of organic compounds |
11/12/2008 | EP1628977B1 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES |
11/12/2008 | EP1549159B1 Beverages containing plant sterols |
11/12/2008 | EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
11/12/2008 | EP1478659B1 Biologically active peptides |
11/12/2008 | EP1365771B9 Method of treating certain eye diseases |
11/12/2008 | EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists |
11/12/2008 | CN201147507Y Long-acting blood pressure-reducing sustained-release degradation stick |
11/12/2008 | CN101305017A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
11/12/2008 | CN101305007A Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors |
11/12/2008 | CN101305000A 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase |
11/12/2008 | CN101304993A Compounds and compositions as ppar modulators |
11/12/2008 | CN101304984A Oxazole and thiazole ppar modulator |
11/12/2008 | CN101304970A Amorphous form of 1,2-dihydropyridine compound |
11/12/2008 | CN101302515A Human antibodies that bind human TNF(alpha) |
11/12/2008 | CN101302246A Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof |
11/12/2008 | CN101302245A Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof |
11/12/2008 | CN101302221A Anti-platelet activating factor compound |
11/12/2008 | CN101302204A Quinazolone compound, composition and application including the same |
11/12/2008 | CN101301477A Isoquercitrin clathrate and preparation thereof |
11/12/2008 | CN101301475A Peg化因子vii糖型 Peg factor vii sugar type |
11/12/2008 | CN101301459A Medicated pillow |
11/12/2008 | CN101301458A Medicament for treating chronic cardiac failure and preparation thereof |
11/12/2008 | CN101301454A Navel plaster with powder for soothing heart |
11/12/2008 | CN101301453A Chinese patent medicine powder for treating hematopathy |
11/12/2008 | CN101301432A Chinese medicinal composition for treating cerebral hemorrhage |
11/12/2008 | CN101301425A Formulation for treating diabetes and promoting coronary circulation and quality control method |
11/12/2008 | CN101301423A Medicament for treating comprehensive hemorrhoid and preparation thereof |
11/12/2008 | CN101301420A Medicament for treating angina pectoris of coronary heart disease |
11/12/2008 | CN101301413A Cordyceps sinensis and Rhodiola rosea capsules and preparation thereof |
11/12/2008 | CN101301411A Chinese medicinal composition for treating angina pectoris |
11/12/2008 | CN101301407A Medicament for treating arthritis and angiitis |
11/12/2008 | CN101301398A Chinese medicine for treating hypertension |
11/12/2008 | CN101301384A Chinese medicinal composition for treating arteriosclerosis |
11/12/2008 | CN101301381A Medicament for treating hypertension |
11/12/2008 | CN101301377A Capsules of compound haw thorn leaf extract |
11/12/2008 | CN101301376A Crataegutt oral freeze-dried tablet and preparation thereof |
11/12/2008 | CN101301370A Method for preparing monoester type alkaloids using Chinese medicinal material of aconitum as raw material |
11/12/2008 | CN101301353A Preparation of Dandengtongnao medicinal formulation and quality control method |
11/12/2008 | CN101301351A Capsules for treating cardiovascular and cerebrovascular diseases and method for preparing the same |
11/12/2008 | CN101301319A Preparation of granada flower polyphenol and uses thereof |
11/12/2008 | CN101301318A Ginkgo leaf extract oral freeze-dried slices and preparation thereof |
11/12/2008 | CN101301311A Potassium magnessium aspartape sterilized powder injection and preparation thereof |
11/12/2008 | CN101301306A Use of DFT in preparing medicament for treating and preventing shock |
11/12/2008 | CN101301304A Chinese medicinal composition for treating ischemic stroke and preparation thereof |
11/12/2008 | CN101301286A Novel use of brasilein |
11/12/2008 | CN101301267A Bilobalide B injection and preparation thereof |
11/12/2008 | CN101301157A Chrysanthemum health care pillow |
11/12/2008 | CN101301062A Health flavouring material edible for patients with elevated blood pressure |
11/12/2008 | CN100432232C Method for extracting polyose from Hojothuria leucospilota, said polyose and its medicine use |
11/12/2008 | CN100432070C Novel sulfamides and their use as endothelin receptor antagonists |
11/12/2008 | CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same |
11/12/2008 | CN100432057C Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
11/12/2008 | CN100432055C Tricyclic protein kinase inhibitors |
11/12/2008 | CN100432049C Cycloalkene derivatives, process for producing the same and use |
11/12/2008 | CN100431611C Compound of polypeptide-liposome and human vascular endothelial growth factor gene recombination plasmid and its use |
11/12/2008 | CN100431604C C1 inhibitor with short half-life for transient treatment |
11/12/2008 | CN100431579C Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn |
11/12/2008 | CN100431575C Medicine composition for treating cardiac and cerebral vascular diseases |
11/12/2008 | CN100431565C Mongolia medicine for treating coronary heart disease and angina pectoris |
11/12/2008 | CN100431562C Chinese traditional medicinal preparation containing red sange root and safflower for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
11/12/2008 | CN100431560C Alcohol in use for reducing blood fat and lowering the blood pressure |
11/12/2008 | CN100431537C Blood fluidity improving agent |
11/12/2008 | CN100431534C Methods of inhibiting vascular permeability and apoptosis |
11/12/2008 | CN100431532C Breviscapine and borneol constituted composite injection formulation and preparation method thereof |
11/12/2008 | CN100431529C Soft capsule for reducing blood fat and its preparing method |
11/11/2008 | US7449581 6-Substituted pyrido-pyrimidines |
11/11/2008 | US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia |
11/11/2008 | US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis |
11/11/2008 | US7449492 Therapeutic agents—I |
11/11/2008 | US7449490 Pharmaceutically active compounds and methods of use |
11/11/2008 | US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc. |
11/11/2008 | US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones |